Michael J. Katovich
M. J. Katovich: Department of Pharmadocynamics
University of Florida
PO Box 100487
SW 1600 Archer Road
USA
Name/email consistency: high
- Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Qi, Y., Shenoy, V., Wong, F., Li, H., Afzal, A., Mocco, J., Sumners, C., Raizada, M.K., Katovich, M.J. Exp. Physiol. (2011)
- Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Katovich, M.J., Grobe, J.L., Raizada, M.K. Curr. Hypertens. Rep. (2008)
- Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension. Katovich, M.J., Grobe, J.L., Huentelman, M., Raizada, M.K. Exp. Physiol. (2005)
- Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension. Katovich, M.J., Reaves, P.Y., Francis, S.C., Pachori, A.S., Wang, H.W., Raizada, M.K. J. Hypertens. (2001)
- Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin. Katovich, M.J., Pachori, A. Diabetes. Obes. Metab (2000)